文献速递血液净化与透析

儿童腹膜透析中普遍出口处抗生素预防可减少出口处感染

Universal Exit-Site Antibiotic Prophylaxis Reduces Exit-Site Infections in Pediatric Peritoneal Dialysis.
PubMed 文献 · Kidney Int Rep · 2025-08-26

结果显示,预防后出口处感染或隧道感染年化率显著降低(0.17 vs 0.46 次/患者年,P=0.003),革兰阳性感染率亦降低,且因腹膜透析相关感染住院天数减少。

要点

  • 普遍出口处抗生素预防可降低儿童腹膜透析患者出口处或隧道感染年化率。
  • 该策略主要减少革兰阳性感染,对革兰阴性、真菌及培养阴性感染无显著影响。
  • 预防后因腹膜透析相关感染导致的住院天数显著减少。

核心结论

  • 每日出口处抗生素预防可预防儿童腹膜透析患者的革兰阳性出口处或隧道感染并缩短住院时间。

主要发现

  • 预防后出口处或隧道感染年化率显著低于预防前(0.17,95%CI 0.07-0.30 vs. 0.46,95%CI 0.29-0.68 次/患者年;P=0.003;发病率比0.34,95%CI 0.14-0.76;P=0.004)。
  • 革兰阳性出口处或隧道感染年化率从0.35(95%CI 0.20-0.54)降至0.10(95%CI 0.04-0.23)次/患者年(P=0.007);革兰阴性、真菌及培养阴性感染率相似。
  • 仅报告4例腹膜炎,组间无显著差异;预防后因腹膜透析相关感染住院天数显著减少(2.08,95%CI 1.72-2.49 vs. 4.22,95%CI 3.68-4.81 天/患者年;发病率比0.49,95%CI 0.39-0.62;P<0.001)。

临床怎么用

  • 在儿童腹膜透析患者中可考虑每日出口处抗生素预防以降低革兰阳性出口处或隧道感染并减少住院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Data on exit-site antibiotic prophylaxis in children undergoing peritoneal dialysis (PD) is scarce. METHODS: We conducted a prospective observational cohort study of pediatric patients (aged < 21 years) who received chronic PD 2 years before (preprophylaxis) and/or 3 years after (postprophylaxis) implementing universal exit-site antibiotic prophylaxis. Catheter and exit-site care remained unchanged. The primary outcomes were annualized rates of exit-site infection (ESI), tunnel infection (TI), and peritonitis. RESULTS: Fifty-seven children (32 girls; 15.1 years, interquartile range: 9.2-17.2) were included. All, except 2 patients underwent automated PD. Thirty-nine and 42 subjects, respectively, received PD during the preprophylaxis and postprophylaxis periods with comparable clinical characteristics. The observation period was 110.0 patient-years. Thirty-seven and 5 patients from the postprophylaxis period received mupirocin and gentamicin, respectively. The annualized ESI or TI rate was significantly lower in the postprophylaxis group (0.17, 95% confidence interval [CI]: 0.07-0.30 vs. 0.46, 95% CI: 0.29-0.68 episodes/patient-yrs; P = 0.003; incidence rate ratio: 0.34, 95% CI: 0.14-0.76; P = 0.004). Annualized rates of gram-positive ESI or TI reduced from 0.35 (95% CI: 0.20-0.54) to 0.10 (95% CI: 0.04-0.23) episodes/patient-yrs (P = 0.007); gram-negative, fungal, and culture-negative ESI or TI rates were similar. Only four peritonitis episodes were reported, with no significant difference between groups. Five catheters were removed in 3 patients because of PD-related infections. Hospitalization days due to PD-related infection were significantly lower in the postprophylaxis group (2.08, 95% CI: 1.72-2.49, vs. 4.22, 95% CI: 3.68-4.81 days/patient-yrs; incidence rate ratio: 0.49, 95% CI: 0.39-0.62; P < 0.001). CONCLUSION: Daily exit-site antibiotic prophylaxis prevents gram-positive ESI or TI and shortens hospital stays in children undergoing PD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chan EY, Zhou D, Siu CW, et al. Universal Exit-Site Antibiotic Prophylaxis Reduces Exit-Site Infections in Pediatric Peritoneal Dialysis. Kidney Int Rep. 2025. PMID: 41278318. doi:10.1016/j.ekir.2025.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。